Approval · Notice of Compliance 29495 · 2022
AKYNZEO: Notice of Compliance 29495
Issued November 16, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29495
- Date
- November 16, 2022
- Company
- Knight Therapeutics Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Change in Product Ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AKYNZEO | 02468735 | Marketed |
Medicinal ingredients
- PALONOSETRON HYDROCHLORIDE 0.5 MG per CAP
- NETUPITANT 300 MG per CAP